Ignite Creation Date:
2024-05-06 @ 3:50 PM
Last Modification Date:
2024-10-26 @ 1:58 PM
Study NCT ID:
NCT04777708
Status:
TERMINATED
Last Update Posted:
2023-03-24
First Post:
2021-02-25
Brief Title:
BO-112 and Pembrolizumab for the Treatment of PD-1PD-L1 Refractory Liver Cancer
Sponsor:
Jonsson Comprehensive Cancer Center
Organization:
Jonsson Comprehensive Cancer Center
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-10-13
Start Date Type:
ACTUAL
Primary Completion Date:
2023-03-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-03-13
Completion Date Type:
ACTUAL
First Submit Date:
2021-02-25
First Submit QC Date:
February 26 2021
Study First Post Date:
2021-03-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-03-22
Last Update Post Date:
2023-03-24
Last Update Post Date Type:
ACTUAL